Printer Friendly

HOWARU Restore reduces side effects of antibiotic use.

A new clinical study on a reformulated version of HOWARU Restore--part of the Danisco range of probiotics from DuPont Nutrition & Health--indicates a reduction in the risk of antibiotic associated diarrhea in patients undergoing antibiotic therapy.

HOWARU Restore, a unique probiotic formulation incorporated into dietary supplements already sold in 10 countries with great success, has a documented ability to replenish intestinal microbiota during gastrointestinal stresses. DuPont has now introduced an optimized formulation of HOWARU Restore comprised of four key strains from the DuPont Danisco strain portfolio: Lactobacillus acidophilus NCFM, Bifidobacterium lactis BI-04. Bifidobacterium lactis Bi-07 and Lactobacillus paracasei Lpc-37.

The new formula was tested on 503 patients undergoing antibiotic therapy in a triple-blind, randomized, placebo-controlled study. The HOWARU Restore formulation demonstrated effectiveness in reducing the impact of antibiotic associated diarrhea in patients under antibiotic therapy with: a significant reduction of the number of episodes of antibiotic associated diarrhea: a significant reduction in the duration of diarrhea and the number of liquid stools: and a significant reduction of diarrhea-associated symptoms such as fever, bloating and abdominal pain. For more information:
COPYRIGHT 2013 Rodman Publishing
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Research Highlights
Publication:Nutraceuticals World
Article Type:Clinical report
Date:Jan 1, 2013
Previous Article:Peak ATP reduces muscle fatigue and maintains muscle strength.
Next Article:American Laboratories, Inc. (ALI).

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters